Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Richard Ziehr, M.D.

Concepts (133)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial3202126280.670 Why?
Coronavirus Infections3202030840.620 Why?
Pulmonary Gas Exchange120203790.620 Why?
Pneumonia, Viral3202032040.610 Why?
Respiratory Mechanics120206990.530 Why?
Prostatic Neoplasms152015111180.510 Why?
Pandemics3202086540.400 Why?
Respiratory Insufficiency1202012300.380 Why?
Physical Phenomena12010480.360 Why?
Ribosomes120105010.280 Why?
Antineoplastic Agents, Hormonal1201415200.270 Why?
Androgen Antagonists1201414100.260 Why?
Income1201418770.260 Why?
Molecular Chaperones120107540.250 Why?
SEER Program7201514500.210 Why?
Healthcare Disparities5201433580.200 Why?
Nitric Oxide Synthase Type III120247050.190 Why?
Coronary Disease1201459140.170 Why?
Exercise Tolerance120248360.160 Why?
Prone Position120201960.160 Why?
Prostatectomy3201518240.150 Why?
Renal Replacement Therapy120202820.150 Why?
Proto-Oncogene Proteins c-myc120239880.150 Why?
Patient Positioning120203260.150 Why?
Administration, Inhalation1202011570.140 Why?
Brachytherapy2201512230.140 Why?
Reference Standards1202010030.140 Why?
Vasoconstrictor Agents120206540.140 Why?
Fluid Therapy120205790.130 Why?
Lactic Acid1202111390.130 Why?
Positive-Pressure Respiration120206390.130 Why?
Vasodilator Agents120209730.130 Why?
Renal Insufficiency120208090.120 Why?
Goserelin120141260.120 Why?
Vascular Endothelial Growth Factor Receptor-2120165460.110 Why?
Anilides120164110.110 Why?
Leuprolide120143120.100 Why?
Insurance Coverage2201419400.100 Why?
Intubation, Intratracheal1202013290.100 Why?
Proto-Oncogene Proteins c-met120165710.100 Why?
Health Status Disparities2201418520.100 Why?
Organs at Risk120143590.100 Why?
Intensive Care Units2202137450.090 Why?
Prostate-Specific Antigen3201524690.090 Why?
Hydroxylamine12010160.090 Why?
Puromycin12010420.090 Why?
Sodium Hydroxide12010370.090 Why?
Ultracentrifugation120101830.090 Why?
Lung Diseases1202019090.090 Why?
Fluorescence Polarization120101400.090 Why?
Edetic Acid120102800.080 Why?
Diabetes Mellitus2202058400.080 Why?
Ribonuclease, Pancreatic120101490.080 Why?
Rectum120148920.080 Why?
Middle Aged1720242208950.080 Why?
Extracorporeal Membrane Oxygenation1202014620.080 Why?
Aged1620211692890.080 Why?
Metformin120159060.070 Why?
Salvage Therapy1201412640.070 Why?
Adenocarcinoma2201563460.070 Why?
Hospital Mortality1202152940.070 Why?
Sepsis1202125850.070 Why?
Aged, 80 and over62020589760.070 Why?
Neoplasms, Second Primary1201510520.070 Why?
Prostate1201517700.070 Why?
Geriatric Assessment1201414100.070 Why?
Protein Folding120108700.070 Why?
Male1920213608040.070 Why?
Humans2420247615040.060 Why?
Comorbidity12020105080.060 Why?
Cohort Studies22020414870.060 Why?
Pyridines1201628750.060 Why?
Risk Factors92021742060.060 Why?
Severity of Illness Index12021158420.050 Why?
Smoking1202090530.050 Why?
Procollagen-Proline Dioxygenase12023810.050 Why?
Body Mass Index12021129530.050 Why?
Escherichia coli Proteins1201010670.050 Why?
United States92021723340.050 Why?
Retrospective Studies62021806360.050 Why?
Protein Biosynthesis1201021130.050 Why?
Insurance, Health1201424980.050 Why?
Cell Hypoxia120236560.050 Why?
Hypertension1202085400.040 Why?
Signal Transduction12023234450.040 Why?
Mutation12024300520.040 Why?
Logistic Models12014132550.040 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120236190.040 Why?
Obesity12021129470.040 Why?
Critical Illness2202127230.040 Why?
Adult720242211770.040 Why?
Vascular Endothelial Growth Factor D12016640.030 Why?
Socioeconomic Factors3201578270.030 Why?
Risk Assessment22015239950.030 Why?
Young Adult22020592430.030 Why?
Neoplasm Recurrence, Local1201492800.030 Why?
Massachusetts2202188300.030 Why?
Europe1202134220.030 Why?
Survival Rate22021127250.030 Why?
Androgen Receptor Antagonists120151250.030 Why?
Patient Protection and Affordable Care Act2201411880.030 Why?
Age Factors32015183950.030 Why?
Minority Health12014790.030 Why?
Diagnosis-Related Groups120154490.030 Why?
Marital Status120154260.030 Why?
Female620243926440.030 Why?
Risk2201596100.030 Why?
Postoperative Complications12014156310.030 Why?
Incidence32015213530.020 Why?
Epidemiologic Methods1201513360.020 Why?
Biopsy, Needle1201516260.020 Why?
Age of Onset1201533050.020 Why?
Magnetic Resonance Imaging12015364260.020 Why?
Radiotherapy Dosage1201428980.020 Why?
Disease-Free Survival1201668140.020 Why?
Kaplan-Meier Estimate1201664840.020 Why?
Neoplasm Metastasis1201649150.020 Why?
Neoplasms12014221700.020 Why?
Molecular Targeted Therapy1201628110.020 Why?
Lung12023100000.010 Why?
Population Surveillance1201425980.010 Why?
Feasibility Studies1201452470.010 Why?
Follow-Up Studies22015391060.010 Why?
Mortality1201429010.010 Why?
Survival Analysis12014100900.010 Why?
Hospitalization12021107230.010 Why?
Prognosis12021296250.010 Why?
Neoplasm Staging12015111210.010 Why?
Protein Kinase Inhibitors1201656710.010 Why?
Databases, Factual1201579670.010 Why?
Predictive Value of Tests12015152660.010 Why?
Quality of Life12014133670.010 Why?
Treatment Outcome12014646800.000 Why?
Ziehr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (133)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.